Showing 41 - 60 results of 113,793 for search '(( i non decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.84s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…(p<0.05; one-way ANOVA). Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
  5. 45
  6. 46
  7. 47

    The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

    Published 2014
    “…Cells were detached by incubation with trypsin/EDTA and collected at each time point. A total of 1×10<sup>6</sup> cells suspended in PBS were incubated with 2.5 µg/ml JC-1 for 10 min at 37°C. …”
  8. 48

    The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

    Published 2014
    “…Cells were detached by incubation with trypsin/EDTA and collected at each time point. A total of 1×10<sup>6</sup> cells suspended in PBS were incubated with 2.5 µg/ml JC-1 for 10 min at 37°C. …”
  9. 49
  10. 50
  11. 51

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…Scale bar 2mV, 3s. (D) Paired-pulse analysis indicates a decrease in release probability in <i>+/-;P[syt<sup>P-L</sup>]/+</i>. …”
  12. 52
  13. 53

    Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease by Gonçalo da Costa (198731)

    Published 2015
    “…Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. …”
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60